Phenylbutazone Drug Interactions
Currently displaying 102 drugs known to have a major interaction with phenylbutazone.
- 102 major drug interactions
- 450 moderate drug interactions
- 19 minor drug interactions
Major interactions with phenylbutazone
Note: Showing generic names only.
A
B
C
- cabozantinib
- celecoxib
- chloramphenicol
- cidofovir
- cladribine
- clozapine
- cytomegalovirus immune globulin
D
- dabigatran
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- deferiprone
- desirudin
- deucravacitinib
- diatrizoate
- diclofenac
- dicumarol
- diflunisal
- drotrecogin alfa
E
F
I
- ibritumomab
- ibrutinib
- ibuprofen
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- indomethacin
- inotersen
- iodamide
- iodine i 131 tositumomab
- iodipamide
- iodixanol
- iohexol
- iomeprol
- iopamidol
- iopromide
- iothalamate
- ioversol
- ioxaglate
- ioxilan
K
L
M
N
O
P
R
- radium 223 dichloride
- ramucirumab
- ranolazine
- regorafenib
- respiratory syncytial virus immune globulin
- rho (d) immune globulin
- rivaroxaban
- rofecoxib
S
T
- tacrolimus
- tenofovir alafenamide
- tenofovir disoproxil
- teriflunomide
- tinzaparin
- tolmetin
- tositumomab
- tovorafenib
U
V
W
Z
Phenylbutazone alcohol/food interactions
There is 1 alcohol/food interaction with phenylbutazone.
Phenylbutazone disease interactions
There are 4 disease interactions with phenylbutazone which include:
More about phenylbutazone
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.